CHE vs CNC · P/E 24, rev $2.43B vs P/E 8.4, rev $163.07B
Chemed Corp (CHE) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the CHE and CNC stock pages for the full models.
Not investment advice.